The 80th Annual Meeting of the Japanese Society of Hematology

Presentation information

Print

Oral Session

Oral Session 3-12B MM: Drug responses

Sun. Oct 14, 2018 9:40 AM - 10:40 AM No.12 (Osaka International Convention Center, 10F 1006-7)

Chair: Naoya Mimura (Department of Transfusion Medicine and Cell Therapy Chiba University Hospital, Japan)

[OS3-12B-5] Not all patients with CCND1-positive multiple myeloma show favorable outcome even with novel agents

Takuto Tachita1, Tomoko Narita1, Masaki Ri1, Takayuki Murase2, Sho Aoki1, Shiori Kinoshita1, Yoshiko Ohshima1, Haruna Fujinami1, Takashi Kanamori1, Haruhito Totani1, Ayako Masaki2, Asahi Ito1, Shigeru Kusumoto1, Hirokazu Komatsu1, Hiroshi Inagaki1, Shinsuke Iida1 (1.Hematology and Oncology, Nagoya City University,Nagoya,Japan, 2.Pathology and Molecular Diagnostics, Nagoya City University,Nagoya,Japan)

Abstract password authentication.
Password is written on a program and abstract book.

Password